Enterprises

Gene Signal International SA

Web www.genesignal.com

Email ev@genesignal.com

Phone+41218046160

Fax+41218046165


PSE, EPFL site

PSE-A - 2nd floor

1015 Lausanne

Start-up/PME

Responsible Mr.   Eric Viaud

Activity domain

Gene Signal is a research and development based biotechnology company focused on discovering genes involved in the regulation of angiogenesis. Gene Signal is currently developing therapeutic solutions based on a family of antisense oligonucleotides (short DNA fragments) to conquer disease associated with significant unmet medical needs despite the advent of VEGF (Vascular Endothelial Growth Factor). Gene Signal is currently completing recruitment for its Phase III study for GS-101 (Aganirsen) in corneal neovascularisation, its most advanced therapeutic ophthalmic solution.

Keywords : Antisense Oligonucleotides, Ophthalmology, Corneal Neovascularisation, Choroidal Neovascularisation